Cart
sales@molnova.com
proline
CAS No. 147-85-3
proline( Proline | CB 1707 | FEMA No. 3319 | HSDB 1210 )
Catalog No. M18044 CAS No. 147-85-3
Proline and its derivatives are often used as asymmetric catalysts in organic reactions, as the CBS reduction and proline catalysed aldol condensation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 39 | In Stock |
|
| 1G | 41 | In Stock |
|
Biological Information
-
Product Nameproline
-
NoteResearch use only, not for human use.
-
Brief DescriptionProline and its derivatives are often used as asymmetric catalysts in organic reactions, as the CBS reduction and proline catalysed aldol condensation.
-
DescriptionProline is a non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons.
-
In Vitro——
-
In Vivo——
-
SynonymsProline | CB 1707 | FEMA No. 3319 | HSDB 1210
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number147-85-3
-
Formula Weight115.13
-
Molecular FormulaC5H9NO2
-
Purity>98% (HPLC)
-
SolubilityH2O : 50 mg/mL 434.29 mM;
-
SMILESC1CC(NC1)C(=O)O
-
Chemical NameL-proline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Brentuximab vedotin
Brentuximab vedotin (SGN-35) is a CD30-targeting antibody-active molecule conjugate (ADC) that combines a CD30 monoclonal antibody with the microtubule disrupting agent monomethylauristatin E for the study of lymphoma.
-
CID-663143
CID-663143 inhibits cancer cell growth and shows microtubule-binding activity.
-
E64FC26
E64FC26 is a potent protein disulfide isomerase (PDI) family pan-inhibitor with antitumor activity, inhibits PDIA1, PDIA3, PDIA4, TXNDC5 and PDIA6, and can be used in the study of multiple myeloma and pancreatic cancer.
